Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $6.0700 (14.96%) ($5.1100 - $6.1000) on Wed. Apr. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 20.33% (three month average) | RSI | 44 | Latest Price | $6.0700(14.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -2.2% a day on average for past five trading days. | Weekly Trend | SONN declines -3.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) USO(-26%) UNG(-1%) KWEB(-18%) JNK(-46%) SPLV(-88%) | Factors Impacting SONN price | SONN will decline at least -10.165% in a week (0% probabilities). HYG(-53%) VXX(1%) XBI(-77%) EEM(-59%) XLRE(-75%) | | | | | Relative Volatility | | | | Market Trend Strength | -10.165% (StdDev 20.33%) | Hourly BBV | 0 () | Intraday Trend | 15% | | | |
|
1 - 5 Day Possible Target | $-88.06(-1550.74%) | Resistance Level | $7.61 | 5 Day Moving Average | $5.77(5.2%) | 10 Day Moving Average | $5.89(3.06%) | 20 Day Moving Average | $7.61(-20.24%) | To recent high | -77.1% | To recent low | 19.3% | Market Cap | $56m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |